Collateral for a security interest recorded Apr 8, 2026 (Royal Bank of Canada).
Term ended no later than Nov 10, 2026 · Medium confidence
20-year base term ended Nov 10, 2026
Held by Hologic, Inc.
Filed Jan 17, 2014 as application 14/158,261 · Granted Oct 6, 2015
Base term, 20 years from filing
Today
Ended no later than Nov 10, 2026
2006
2026
Clock starts
Nov 10, 2006
Nov 10, 2006
Ended no later than
Nov 10, 2026
Nov 10, 2026
Granted
Oct 6, 2015
Oct 6, 2015
base term
after the term ends
fee events
Updated Nov 20, 2026 · includes USPTO assignment data published Nov 19, 2026, status data published Nov 20, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
None
Term adjustment
No prosecution delay on this record.
Unresolved
Terminal disclaimer
On file, reference document not resolved, so the date above is an upper bound. We do not guess the cap.
2 of 2
Maintenance fees paid
Two maintenance fees can end this term early, the ones due 3.5 and 7.5 years from grant; the third one's grace period runs past the term end. This counts the ones the record shows paid.
4
Family applications on record here
Applications sharing this one's continuity chain, as the file histories and patent records this site holds name them. The family may have others.
This patent's term is its 20-year base term, with no adjustment for prosecution delay. A terminal disclaimer is on file with no resolved reference, so no cap is applied and none is guessed. Confidence: Medium. from the record
How we calculated this date
One row per rule, each showing its own input and what it did to the date. A step we could not verify says so instead of resolving itself.
| Step | Input | Date after this step | Confidence |
|---|---|---|---|
| Base term, 20 years from filing | Clock starts Nov 10, 2006, when application PCT/US2006/043730, the earliest non-provisional in its chain, was filed (this one was filed Jan 17, 2014) | Nov 10, 2026 | High confidence |
| Continuity chain | Every parent in the chain resolved | no change | High confidence |
| Patent term adjustment | None on file | no change | High confidence |
| Terminal disclaimer cap | Disclaimer on file (approved), reference document not resolved | no cap applied, and none guessed | Medium confidence |
| Patent term extension | None on file | no change | High confidence |
| Fee events | 2 of 2 maintenance fees paid | term ended | High confidence |
| Computed term end | The steps above, in order | no later than Nov 10, 2026 | Medium confidence |
This family
| Application 60/735,741 | Provisional application no patent term | no patent term |
| Application PCT/US2006/043730 | PCT application no patent term | no patent term |
| US 8,634,629 | In force Jun 2029 | Jun 2029 |
| US 9,153,021 | this patent no later than Nov 2026 | no later than Nov 2026 |
Every application listed has its file history here. The family may have others.
Assignments
Assignment documents as recorded at the USPTO, oldest first, with the reel and frame each was recorded at. A recorded assignment is a filed document, not a statement of current ownership, and the absence of a later one is not evidence that the last one still stands.
| Recorded | Assignor | Assignee | Conveyance |
|---|---|---|---|
| Apr 15, 2014 Reel 32676, frame 670 | Wilson, Kevin | Hologic, Inc. | Assignment of Assignor's Interest |
| Apr 25, 2014 Reel 32753, frame 942 | Hologic, Inc.; Biolucent, LLC; Cytyc Corporation; Cytyc Surgical Products, Limited; Direct Radiography Corp.; Suros Surgical Systems, Inc.; Third Wave Technologies, Inc.; Gen-Probe Incorporated | Goldman Sachs Bank, USA | Security Interest |
| Jun 3, 2015 Reel 35813, frame 1 | Goldman Sachs Bank USA, as Collateral Agent | Hologic, Inc.; Biolucent, LLC; Cytyc Corporation; Cytyc Surgical Products, Limited Partnership; Direct Radiography Corp.; Suros Surgical Systems, Inc.; Third Wave Technologies, Inc.; Gen-Probe Incorporated | Security Interest Release Reel/Frame 032753/0942 |
| Jun 3, 2015 reel/frame not recorded | Goldman Sachs Bank USA, as Collateral Agent | Hologic, Inc. | Security Interest Release Reel/Frame 032753/0942 |
| Jun 3, 2015 reel/frame not recorded | Goldman Sachs Bank USA, as Collateral Agent | Biolucent, LLC | Security Interest Release Reel/Frame 032753/0942 |
| Jun 3, 2015 reel/frame not recorded | Goldman Sachs Bank USA, as Collateral Agent | Cytyc Corporation | Security Interest Release Reel/Frame 032753/0942 |
| Jun 3, 2015 reel/frame not recorded | Goldman Sachs Bank USA, as Collateral Agent | Cytyc Surgical Products, Limited Partnership | Security Interest Release Reel/Frame 032753/0942 |
| Jun 3, 2015 reel/frame not recorded | Goldman Sachs Bank USA, as Collateral Agent | Direct Radiography Corp. | Security Interest Release Reel/Frame 032753/0942 |
| Jun 3, 2015 reel/frame not recorded | Goldman Sachs Bank USA, as Collateral Agent | Suros Surgical Systems, Inc. | Security Interest Release Reel/Frame 032753/0942 |
| Jun 3, 2015 reel/frame not recorded | Goldman Sachs Bank USA, as Collateral Agent | Third Wave Technologies, Inc. | Security Interest Release Reel/Frame 032753/0942 |
| Jun 3, 2015 reel/frame not recorded | Goldman Sachs Bank USA, as Collateral Agent | Gen-Probe Incorporated | Security Interest Release Reel/Frame 032753/0942 |
| Aug 7, 2015 Reel 36307, frame 199 | Hologic, Inc.; Biolucent, LLC; Cytyc Corporation; Cytyc Surgical Products, Limited Partnership; Direct Radiography Corp.; Gen-Probe Incorporated; Gen-Probe Prodesse, Inc.; Suros Surgical Systems, Inc.; Third Wave Technologies, Inc. | Bank of America, N.A., as Collateral Agent | Security Agreement |
| Apr 8, 2026 Reel 75462, frame 440 | Biotheranostics, Inc.; Gen-Probe Incorporated; Gen-Probe Prodesse, Inc.; Cytyc Corporation; Suros Surgical Systems, Inc.; Gynesonics, Inc.; Bolder Surgical, LLC; Faxitron Bioptics, LLC; Health Beacons, Inc.; Hologic, Inc. | Royal Bank of Canada, as Collateral Agent | Security Interest |
| Apr 8, 2026 Reel 75926, frame 339 | Biotheranostics, Inc.; Gen-Probe Incorporated; Gen-Probe Prodesse, Inc.; Cytyc Corporation; Suros Surgical Systems, Inc.; Gynesonics, Inc.; Bolder Surgical, LLC; Faxitron Bioptics, LLC; Health Beacons, Inc.; Hologic, Inc. | Citibank, N.A., as Collateral Agent | Security Interest |
| Apr 28, 2026 Reel 75566, frame 39 | Bank of America, N.A., as Collateral Agent | Hologic, Inc., on Its Own Behalf and as Successor-by-Merger to Direct Radiography Corp.; Cytyc Corporation, on Its Own Behalf and as Successor-by-Merger to Biolucent, LLC; Cytyc Surgical Products, LLC, as Successor-by-Conversion to Cytyc Surgical Products, Limited Partnership; Gen-Probe Incorporated, on Its Own Behalf and as Successor-by-Merger to Third Wave Technologies, Inc.; Gen-Probe Prodesse, Inc.; Suros Surgical Systems, Inc. | Release of Security Interest |
Sources
Google Patents · The patent document at USPTO · Assignment records at USPTO
USPTO account required: This application in Patent Center · USPTO's maintenance fee lookup
Maintenance fee events come from USPTO's own fee records. Its fee lookup asks for the patent number and the application number.
What's changing
Note
A terminal disclaimer is on file and its reference is not resolved. No cap is applied and none is guessed
Open question
A terminal disclaimer is on file (approved) and its reference document is not resolved. A disclaimer would cap the term earlier than Nov 10, 2026. We will not guess the cap.
Citations
11
later US patents cite this one
That is above the median of utility patents granted in 2015 in our data, the only group it is compared against.
How we rank
Every date shows its work: the base term, any term adjustment or extension, any disclaimer cap, and the maintenance fee record, each with a confidence tier. How this record was built
This computed term ends no later than the date shown; an unresolved terminal disclaimer may end it earlier. Related patents and pending applications may cover overlapping subject matter.